Evidence-Based Medicine Guidelines
Continuous versus intermittent beta-agonists in the treatment of acute asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Continuous Versus Intermittent Beta-agonists in the Treatment of Acute Asthma." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453313/all/Continuous_versus_intermittent_beta_agonists_in_the_treatment_of_acute_asthma.
Continuous versus intermittent beta-agonists in the treatment of acute asthma. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453313/all/Continuous_versus_intermittent_beta_agonists_in_the_treatment_of_acute_asthma. Accessed March 16, 2025.
Continuous versus intermittent beta-agonists in the treatment of acute asthma. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453313/all/Continuous_versus_intermittent_beta_agonists_in_the_treatment_of_acute_asthma
Continuous Versus Intermittent Beta-agonists in the Treatment of Acute Asthma [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453313/all/Continuous_versus_intermittent_beta_agonists_in_the_treatment_of_acute_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuous versus intermittent beta-agonists in the treatment of acute asthma
ID - 453313
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453313/all/Continuous_versus_intermittent_beta_agonists_in_the_treatment_of_acute_asthma
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
